103 related articles for article (PubMed ID: 1698166)
1. The production and characterisation of monoclonal antibodies to myc, c-erbB-2 and EFG-receptor using a synthetic peptide approach.
Price KM; Cuthbertson AS; Varndell IM; Sheppard PW
Dev Biol Stand; 1990; 71():23-31. PubMed ID: 1698166
[TBL] [Abstract][Full Text] [Related]
2. Expression of the c-erbB-3 protein in normal human adult and fetal tissues.
Prigent SA; Lemoine NR; Hughes CM; Plowman GD; Selden C; Gullick WJ
Oncogene; 1992 Jul; 7(7):1273-8. PubMed ID: 1377811
[TBL] [Abstract][Full Text] [Related]
3. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas.
Poller DN; Spendlove I; Baker C; Church R; Ellis IO; Plowman GD; Mayer RJ
J Pathol; 1992 Nov; 168(3):275-80. PubMed ID: 1361526
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues.
Gullick WJ; Hughes CM; Mellon K; Neal DE; Lemoine NR
J Pathol; 1991 Aug; 164(4):285-9. PubMed ID: 1681040
[TBL] [Abstract][Full Text] [Related]
5. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
[TBL] [Abstract][Full Text] [Related]
6. Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.
Rajkumar T; Gooden CS; Lemoine NR; Gullick WJ; Goden CS
J Pathol; 1993 Jul; 170(3):271-8. PubMed ID: 8133400
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.
Motté P; Alberici G; Ait-Abdellah M; Bellet D
J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187
[TBL] [Abstract][Full Text] [Related]
8. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against an identical short peptide sequence shared by two unrelated proteins.
Schulze-Gahmen U; Wilson IA
Pept Res; 1989; 2(5):322-31. PubMed ID: 2485209
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
11. New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E.
Lang MS; Oostendorp RA; Simons PJ; Boersma W; Knegt P; van Ewijk W
Cancer Res; 1994 Apr; 54(7):1831-6. PubMed ID: 7511054
[TBL] [Abstract][Full Text] [Related]
12. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
Wang X; Campoli M; Cho HS; Ogino T; Bandoh N; Shen J; Hur SY; Kageshita T; Ferrone S
J Immunol Methods; 2005 Apr; 299(1-2):139-51. PubMed ID: 15896802
[TBL] [Abstract][Full Text] [Related]
13. Specific antibody response towards predicted epitopes of the epidermal growth factor receptor induced by a thermostable synthetic peptide adjuvant conjugate.
Muller CP; Bühring HJ; Becker G; Jung CC; Jung G; Tröger W; Saalmüller A; Wiesmuller KH; Bessler WG
Clin Exp Immunol; 1989 Dec; 78(3):499-504. PubMed ID: 2482148
[TBL] [Abstract][Full Text] [Related]
14. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.
Alper O; Yamaguchi K; Hitomi J; Honda S; Matsushima T; Abe K
Cell Growth Differ; 1990 Dec; 1(12):591-9. PubMed ID: 1981143
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic characterization of epitope-specific monoclonal antibodies against the myc family proteins.
Ikegaki N; Kennett RH
Oncogene; 1990 Mar; 5(3):397-403. PubMed ID: 1690381
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
18. Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.
Klapper LN; Waterman H; Sela M; Yarden Y
Cancer Res; 2000 Jul; 60(13):3384-8. PubMed ID: 10910043
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
Wikstrand CJ; Hale LP; Batra SK; Hill ML; Humphrey PA; Kurpad SN; McLendon RE; Moscatello D; Pegram CN; Reist CJ
Cancer Res; 1995 Jul; 55(14):3140-8. PubMed ID: 7606735
[TBL] [Abstract][Full Text] [Related]
20. Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sites.
Epstein RJ
Oncogene; 1995 Jul; 11(2):315-23. PubMed ID: 7624146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
